PULMOZYME 2500 U/2,5 ml, solution pour inhalation par nébuliseur — 30 ampoule(s) polyéthylène de 2,5 ml

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400949005666
  • CIP7 4900566
  • CIS 63385292

What the source publishes

Holder
CRISTERS
Active ingredients
DÉSOXYRIBONUCLÉASE
Form
solution pour inhalation par nébuliseur
Package
30 ampoule(s) polyéthylène de 2,5 ml
Routes
inhalée
Administrative status
authorised
Supply regime
prescription initiale hospitalière semestrielle ; liste I ; renouvellement non restreint
Marketing status
Déclaration de commercialisation
Authorised on
2024-05-30
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400949005666
{
  "cis": "63385292",
  "cip7": "4900566",
  "form": "solution pour inhalation par nébuliseur",
  "name": "PULMOZYME 2500 U/2,5 ml, solution pour inhalation par nébuliseur — 30 ampoule(s) polyéthylène de 2,5 ml",
  "cip13": "3400949005666",
  "holder": "CRISTERS",
  "routes": [
    "inhalée"
  ],
  "holders": [
    "CRISTERS"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "754.03",
  "authorisedOn": "2024-05-30",
  "compositions": [
    {
      "name": "DÉSOXYRIBONUCLÉASE",
      "nature": "SA",
      "strength": "2500 U (2,5 mg)",
      "linkageNumber": "1",
      "substanceCode": "05291",
      "dosageReference": "2,5 ml",
      "pharmaceuticalElement": "solution"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "prescription initiale hospitalière semestrielle ; liste I ; renouvellement non restreint",
  "dispensingFee": "1.02",
  "medicinePrice": "753.01",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "PULMOZYME 2500 U/2,5 ml, solution pour inhalation par nébuliseur",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "30 ampoule(s) polyéthylène de 2,5 ml",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "30 %"
  ],
  "marketingDeclaredOn": "2024-10-04",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "DÉSOXYRIBONUCLÉASE"
  ],
  "authorisationProcedure": "Autorisation d'importation parallèle",
  "prescriptionConditions": [
    "prescription initiale hospitalière semestrielle",
    "liste I",
    "renouvellement non restreint"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400949005666"